
Senseonics Holdings SENS
$ 7.05
0.0%
Annual report 2025
added 03-02-2026
Senseonics Holdings Shares 2011-2026 | SENS
Annual Shares Senseonics Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.7 M | 31.5 M | 568 M | 422 M | 237 M | 189 M | 157 M | 116 M | 89.2 M | 91.6 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 568 M | 31.5 M | 194 M |
Quarterly Shares Senseonics Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45 M | 813 M | 719 M | 29.8 M | 31 M | 617 M | 615 M | 530 M | 592 M | 567 M | 497 M | 480 M | 472 M | 464 M | 456 M | 447 M | 445 M | 432 M | 364 M | 266 M | 237 M | 220 M | 204 M | 203 M | 197 M | 177 M | 177 M | 177 M | 176 M | 139 M | 137 M | 137 M | 129 M | 104 M | 93.9 M | 93.6 M | 93.4 M | 92.7 M | 77.3 M | 75.8 M | 1.96 M | 1.95 M | 138 M | 10.5 M | 120 M | 10.2 M | 10 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 813 M | 1.95 M | 258 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
304 M | $ 116.96 | 1.23 % | $ 35.6 B | ||
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | ||
|
Co-Diagnostics
CODX
|
1.33 M | $ 1.72 | 2.99 % | $ 2.29 M | ||
|
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
27.8 M | $ 25.0 | 2.21 % | $ 694 M | ||
|
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
53.3 M | $ 21.37 | 0.66 % | $ 1.14 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M | ||
|
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
30.2 M | $ 16.33 | 0.12 % | $ 494 M | ||
|
Illumina
ILMN
|
159 M | $ 128.0 | 0.09 % | $ 20.4 B | ||
|
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
49.6 M | $ 171.98 | 1.3 % | $ 8.52 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
125 M | $ 88.84 | -0.08 % | $ 11.1 B | ||
|
Lantheus Holdings
LNTH
|
67.5 M | $ 84.31 | -0.03 % | $ 5.69 B | ||
|
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
4.42 M | $ 1.98 | -2.37 % | $ 8.76 M | ||
|
Medpace Holdings
MEDP
|
28.8 M | $ 412.77 | 0.54 % | $ 11.9 B | ||
|
Koninklijke Philips N.V.
PHG
|
904 M | $ 27.63 | 0.58 % | $ 20 B | ||
|
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
217 M | $ 9.6 | 0.58 % | $ 2.08 B | ||
|
Biomerica
BMRA
|
2.3 M | $ 2.12 | -0.93 % | $ 4.87 M | ||
|
National Research Corporation
NRC
|
22.4 M | $ 17.33 | 0.55 % | $ 388 M | ||
|
ICON Public Limited Company
ICLR
|
82.5 M | $ 101.21 | -0.94 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 263.81 | 0.03 % | $ 21.9 B | ||
|
Thermo Fisher Scientific
TMO
|
377 M | $ 473.8 | 0.9 % | $ 179 B | ||
|
Celcuity
CELC
|
46.8 M | $ 125.71 | 3.87 % | $ 5.88 B | ||
|
Trinity Biotech plc
TRIB
|
83.6 M | $ 0.64 | -1.34 % | $ 61.9 M | ||
|
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
128 M | $ 8.41 | 1.45 % | $ 1.08 B | ||
|
Twist Bioscience Corporation
TWST
|
59.8 M | $ 61.16 | 0.36 % | $ 3.66 B | ||
|
Myriad Genetics
MYGN
|
92.6 M | $ 4.91 | 2.72 % | $ 455 M | ||
|
Natera
NTRA
|
98.4 M | $ 206.02 | 1.11 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
111 M | $ 196.49 | 0.14 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
117 M | - | -0.91 % | $ 14.7 B | ||
|
Organovo Holdings
ONVO
|
1.46 M | - | -2.3 % | $ 19.4 M |